Edit

The Vertical Group

https://www.vertical-group.com

Last activity: 16.03.2025

Active

The Vertical Group is a venture capital firm that is focused on the fields of medical technology and biotechnology. For more than 30 years, the principals of The Vertical Group have been founders, early stage investors, major shareholders, and executives of many of the medical technology industry's most successful companies. The Vertical Group is the successor to the venture capital division of F Eberstadt & Co., and has been an independent firm since 1988.

The Vertical Group is headquartered in Basking Ridge, New Jersey, and has an office in San Mateo, California.

Portfolio

Mentions

Location: United States, New Jersey

Employees: 11-50

Founded date: 1988

Investment Type: Venture Capital

Investment Stage: Pre-Seed; Seed; Series A

Portfolio 1

Date	Name	Website	Total Raised	Location
13.12.2006	Elron Vent...	elronventures.com	$52M	Israel, Te...

Mentions in press and media 21

Date	Title	Description
17.03.2025	MicroTransponder Secures $65 Million to Revolutionize Stroke Recovery	In the heart of Austin, Texas, a medical device company is making waves. MicroTransponder has just raised $65 million in Series F funding. This investment is a significant step forward in the company’s mission to transform stroke recovery. ...
16.03.2025	MicroTransponder: $65 Million (Series F) Raised For Enhancing Vivistim Adoption For Chronic Stroke Recovery	MicroTransponder – which is one of the fastest-growing stroke companies – announced it is transforming the stroke continuum of care with its FDA-approved Vivistim Paired VNS System. The company also announced it has raised $75 million led b...
13.03.2025	MicroTransponder Raises $65M in Series F Funding	MicroTransponder, an Austin, TX-based medical device company, raised $65M in Series F funding. The round was led by US Venture Partners (USVP) and the syndicate of current investors, Osage University Partners, Action Potential Venture Capit...
24.07.2017	Hinge Health raises $8M to support expansion of remote monitoring program for chronic pain	The new funding will be used to expand the company’s program for chronic lower back and knee pain and to add treatment programs for hip, shoulder, and neck pain. Having started the year with eight staff, the digital health business plans to...
21.03.2017	When Omada Health was young: the early years	One of the pioneers in digital therapeutics, Omada has largely stayed true to its vision Editor's note: Our Splash Health, Wellness and Wearables event is coming up on March 23 in San Francisco. We'll have Sean Duffy (Co-Founder & CEO, ...
20.05.2015	Dialysis on demand: Outset Medical raises $60M for simple at-home device that treats kidney failure	There’s been a movement to allow patients to undergo dialysis at home – but even then, the training time takes up to two months. It’s not exactly simple. Outset’s blood-filtering device, called the Tablo, filters and purifies regular tap wa...
04.04.2013	Stealthy AtheroMed raises $6M for peripheral atherectomy device	AtheroMed said it’s raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings. The Menlo Park, Calif.-based medical device company is developing an atherectomy device for tre...
17.12.2012	Cancer therapeutic that causes “executioner” protein to kill cancer cells raises $5M	The latest financing follows a $6 million fresh capital raise last year. In October 2010, it raised $32 million in a Series C round. Among the company’s institutional investors are Clarus Ventures, HealthCare Ventures, Quaker Partners, Novi...
22.11.2011	Spine disc replacement firm Flexuspine adds $2.1M to series B round	Jannetty said the company has started the trial, but wouldn’t reveal any more about it. Flexuspine is also performing studies at international sites, with the aim of using data from those studies to support a pivotal trial in the U.S. Flexu...
08.06.2010	Orthodpedic firm Tornier Inc. files for $205 million IPO	Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev...
08.06.2010	Tornier Inc. readies $205 million IPO	By Thomas Lee Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina,...
11.06.2009	Sans IPO, Bayhill secures $350M in Genentech licensing deal	Months after giving up on its IPO hopes last year — when the market was especially brutal for lifescience companies — Bayhill Therapeutics has landed a licensing deal worth $25 million in upfront cash and equity with Genentech. It could bri...
10.04.2009	Cell Biosciences to launch new tech with $10M	Cell Biosciences announced that it’s just brought in $10 million in a third round of funding to launch its new protein analysis technology used to track cellular pathways. It plans to sell its products to labs and research institutions that...
04.11.2008	OncoMed nabs $93M for stem cell programs	OncoMed Pharmaceuticals, a company working to fight cancer using stem cells, added a $93 million tranche to a second round of funding that now totals $154 million. The money will be used to push its lead antibody candidate through phase-two...
09.09.2008	Proteolix raises $79M for cancer treatment	Proteolix, which is developing drugs to treat cancer by disrupting key cell functions, has raised $79 million in a third round of funding, according to VentureWire. That’s the third largest biotech funding this year. Nomura Phase4 Ventures,...
12.07.2007	Entrigue Surgical raises $6.3M for ear, nose and throat	Entrigue Surgical, a San Antonio, Tex., medical-devices maker, raised $6.3 million in a first funding round, VentureWire reports (subscription requires), crediting the San Antonio Express-News (no link available). Vertical Group and Prism V...
-	Hinge Health raises $8M to support expansion of remote monitoring program for chronic pain	Hinge Health, a healthcare startup that wants to help employers cut down their medical costs, has closed an $8 million Series A round. The San Francisco company believes a 12-week remote monitoring program to improve patient education, moni...
-	Cancer therapeutic that causes “executioner” protein to kill cancer cells raises $5M	A company with a small molecule cancer treatment to combat solid tumor cancers as well as hematological malignancies has raised $5 million in a combination of debt, options and warrants, according to a Form D filing with the Securities and ...
-	Spine disc replacement firm Flexuspine adds $2.1M to series B round	Flexuspine, which is developing a total spine disc replacement system, has added $2.1 million to a larger series B round of investment funding. CEO Vin Jannetty declined to reveal any more information about the Pittsburgh-based company’s pa...
-	Dialysis on demand: Outset Medical raises $60M for simple at-home device that treats kidney failure	Bay Area startup Outset Medical has built an at-home hemodialysis machine that’s meant to be simple for consumers with kidney failure to use – and has raised an impressive swath of capital to do so. The Warburg Pincus-backed Outset just rai...
-	Orthodpedic firm Tornier Inc. files for $205 million IPO	Tornier Inc. is planning to test the choppy waters of Wall Street with an estimated $205 million initial public offering, according to documents filed with the Securities and Exchange Commission. The orthopedics firm in Edina, Minn., which ...

The Vertical Group

Portfolio 1

Mentions in press and media 21

Reviews 0